- Home
- HIMS
as 02-24-2025 9:51am EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 8.8B | IPO Year: | N/A |
| Target Price: | $29.86 | AVG Volume (30 days): | 23.3M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.36 - $72.98 | Next Earning Date: | 02-24-2025 |
| Revenue: | $1,241,994,000 | Revenue Growth: | 56.70% |
| Revenue Growth (this year): | 71.44% | Revenue Growth (next year): | 40.33% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chi Michael | HIMS | Chief Commercial Officer | Feb 19 '25 | Sell | $59.26 | 7,500 | $444,450.00 | 193,601 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Feb 18 '25 | Sell | $58.67 | 175,661 | $10,230,063.10 | 427,796 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Feb 18 '25 | Sell | $60.69 | 4,152 | $251,984.88 | 157,345 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Feb 10 '25 | Sell | $43.13 | 11,581 | $498,100.46 | 110,177 | |
| Chi Michael | HIMS | Chief Commercial Officer | Feb 10 '25 | Sell | $43.28 | 7,259 | $314,169.52 | 193,601 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Feb 4 '25 | Sell | $39.12 | 11,581 | $450,730.07 | 110,177 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Feb 3 '25 | Sell | $35.30 | 4,153 | $146,600.90 | 157,345 | |
| Chi Michael | HIMS | Chief Commercial Officer | Feb 3 '25 | Sell | $35.30 | 2,054 | $72,506.20 | 193,601 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Jan 31 '25 | Sell | $35.22 | 100,000 | $3,522,300.00 | 427,796 | |
| Chi Michael | HIMS | Chief Commercial Officer | Jan 24 '25 | Sell | $31.00 | 17,304 | $536,424.00 | 193,601 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 hours ago
Estimating The Intrinsic Value Of Hims & Hers Health, Inc. (NYSE:HIMS)
Investor's Business Daily
3 days ago
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Yahoo Finance Video
3 days ago
Hims & Hers shares dive on end of weight loss drug shortage
Yahoo Finance Video
3 days ago
CrowdStrike, Hims & Hers, Rivian: Market Minute
Business Wire
3 days ago
Hims & Hers Acquires US-based Peptide Facility
TipRanks
4 days ago
Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz
Yahoo Finance
5 days ago
'Health insurance companies are always going to need a PBM': CVS president Prem Shah
Yahoo Finance Video
5 days ago
Hims & Hers Health surges on acquisition for at-home testing
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.